Additionally, tumor-derived microvesicles can activate platelets, which in turn release growth factors such as TGF-β and VEGF, contributing to the remodeling of the tumor microenvironment and facilitating immune evasion and neovascularization. Here, TGFB1 is linked to neoplasm.